From Unilever, Englewood Cliffs, NJ (DAB); Tufts University, Jean Mayer Human Nutrition Research Center on Aging, Boston, MA (JTD); University of Illinois at Urbana-Champaign, Urbana-Champaign, IL (JWE); Purdue University, West Lafayette, IN (MGF); The Sugar Association, Washington, DC (PCG); USDA Agricultural Research Service, Beltsville, MD (JMH); and Mars, Incorporated, McLean, VA (CLK-U).
Am J Clin Nutr. 2015 Jun;101(6):1113-25. doi: 10.3945/ajcn.113.071274. Epub 2015 Apr 8.
Numerous observational and intervention-based human studies support the notion of a beneficial role for dietary flavonoids in human health. Despite these studies, it is not yet possible to make dietary recommendations with regard to the types and amounts of flavonoids to be consumed. The inherent diversity of flavonoid structure, chemistry, and natural distribution in foods lends itself to errors in reporting the types and/or amounts of flavonoids consumed, as well as incomplete recognition of requirements for intervention studies that aim to assess their benefits in a clinical setting. A need exists for guidelines that facilitate the design and reporting of flavonoid research. With a focus on clinical studies, this article 1) outlines limitations commonly encountered in the field of flavonoid research, including the inconsistent use of nomenclature, inappropriate analytic methods, inconsistent use of existing flavonoid databases, and the lack of full consideration in the design of test materials for intervention trials, and 2) provides guidance for future studies with a focus on clinical intervention trials. Adoption of this guidance will facilitate more accurate and interpretable research that will support the development of dietary recommendations regarding the intake of flavonoids.
大量观察性和基于干预的人体研究支持了饮食类黄酮对人类健康有益的观点。尽管有这些研究,但目前还不可能就食用类黄酮的类型和数量提出饮食建议。类黄酮结构、化学性质和在食物中的天然分布的固有多样性导致报告所消耗的类黄酮的类型和/或数量时容易出现错误,并且不完全认识到需要进行干预研究,以评估其在临床环境中的益处。需要制定指南,以促进类黄酮研究的设计和报告。本文重点关注临床研究,1)概述了类黄酮研究领域中常见的局限性,包括命名法使用不一致、分析方法不当、现有类黄酮数据库使用不一致,以及在干预试验测试材料的设计中缺乏全面考虑,2)为未来的临床干预试验研究提供了指导。采用这一指导原则将有助于进行更准确和可解释的研究,从而支持制定关于类黄酮摄入量的饮食建议。